In 2008, Rimonabant (also known as SR141716) was withdrawn from the market worldwide after being approved in 2006 due to serious psychiatric side effects that outweighed its benefits, including suicide
Supplementary Information Rights and permissions Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material
She was named a Top 40 Under 40 Attorney by the American Institute of Trial Lawyers and has been honored as a member of both the Million Dollar Advocates Forum and the Multi-Million Dollar Advocates Forum distinctions reserved for attorneys who have achieved significant results in complex cases
Neuroscience (1997) 77:25770
Rolls BJ, Roe LS, Meengs JS
